Russian pharmaceutical companies: Business models of market leaders

Nataliya A. Kravchenko; Almira T. Yusupova

doi:10.32609/0042-8736-2019-8-127-138

Russian pharmaceutical companies: Business models of market leaders

Nataliya A. Kravchenko, Almira T. Yusupova

Research output: Contribution to journal › Article › peer-review

Abstract

Many factors influence firms’ growth possibilities and market positions. This paper deals with business models as company’s competitiveness determinant; the case of Russian leading pharmaceutical companies is studied. The review of global pharmaceutical leaders’ business models is presented. Russian leaders are indentified basing on empirical data provided by SPARK database. It has been found that they use models of disruptive research, models aimed at business value growth as well as models of active portfolio management. Characteristics and perspectives of each model type are determined.

Original language	English
Pages (from-to)	127-138
Number of pages	12
Journal	Voprosy Ekonomiki
Volume	2019
Issue number	8
DOIs	https://doi.org/10.32609/0042-8736-2019-8-127-138
Publication status	Published - Aug 2019

Keywords

Business models
Pharmaceutical industry
Russian leading companies
business models
pharmaceutical industry

OECD FOS+WOS

5.02.GY ECONOMICS

State classification of scientific and technological information

06 ECONOMY AND ECONOMIC SCIENCE

Access to Document

10.32609/0042-8736-2019-8-127-138

Cite this

@article{25a3cf41034b4a859f4f10c3556f03aa,

title = "Russian pharmaceutical companies: Business models of market leaders",

abstract = "Many factors influence firms{\textquoteright} growth possibilities and market positions. This paper deals with business models as company{\textquoteright}s competitiveness determinant; the case of Russian leading pharmaceutical companies is studied. The review of global pharmaceutical leaders{\textquoteright} business models is presented. Russian leaders are indentified basing on empirical data provided by SPARK database. It has been found that they use models of disruptive research, models aimed at business value growth as well as models of active portfolio management. Characteristics and perspectives of each model type are determined.",

keywords = "Business models, Pharmaceutical industry, Russian leading companies, business models, pharmaceutical industry",

author = "Kravchenko, {Nataliya A.} and Yusupova, {Almira T.}",

year = "2019",

month = aug,

doi = "10.32609/0042-8736-2019-8-127-138",

language = "English",

volume = "2019",

pages = "127--138",

journal = "Voprosy Ekonomiki",

issn = "0042-8736",

publisher = "Voprosy Ekonomiki",

number = "8",

}

TY - JOUR

T1 - Russian pharmaceutical companies

T2 - Business models of market leaders

AU - Kravchenko, Nataliya A.

AU - Yusupova, Almira T.

PY - 2019/8

Y1 - 2019/8

N2 - Many factors influence firms’ growth possibilities and market positions. This paper deals with business models as company’s competitiveness determinant; the case of Russian leading pharmaceutical companies is studied. The review of global pharmaceutical leaders’ business models is presented. Russian leaders are indentified basing on empirical data provided by SPARK database. It has been found that they use models of disruptive research, models aimed at business value growth as well as models of active portfolio management. Characteristics and perspectives of each model type are determined.

AB - Many factors influence firms’ growth possibilities and market positions. This paper deals with business models as company’s competitiveness determinant; the case of Russian leading pharmaceutical companies is studied. The review of global pharmaceutical leaders’ business models is presented. Russian leaders are indentified basing on empirical data provided by SPARK database. It has been found that they use models of disruptive research, models aimed at business value growth as well as models of active portfolio management. Characteristics and perspectives of each model type are determined.

KW - Business models

KW - Pharmaceutical industry

KW - Russian leading companies

KW - business models

KW - pharmaceutical industry

UR - http://www.scopus.com/inward/record.url?scp=85073384479&partnerID=8YFLogxK

U2 - 10.32609/0042-8736-2019-8-127-138

DO - 10.32609/0042-8736-2019-8-127-138

M3 - Article

AN - SCOPUS:85073384479

VL - 2019

SP - 127

EP - 138

JO - Voprosy Ekonomiki

JF - Voprosy Ekonomiki

SN - 0042-8736

IS - 8

ER -

Russian pharmaceutical companies: Business models of market leaders

Abstract

Keywords

OECD FOS+WOS

State classification of scientific and technological information

Access to Document

Other files and links

Fingerprint

Cite this